As acknowledged in the limitation section and noted by the reviewer, the rarity of these tumors and the small number of patients in most series, including ours, limits analysis. Hence, we did not aim to generalize our outcome. Our focus was on how the use of these modern tools can facilitate maximum safe tumor removal which is considered a pivotal factor in the management of chordoma and chondrosarcoma.
The results, while admirable, cannot easily be compared to other series, as the numbers are small and each case has its own complex series of characteristics that make it unique.